Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 193 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1041. Clear
Clear
Q1
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. for BLUE CROSS AND BLUE SHIELD OF KANSAS INC
1st Quarter (Jan 1 - Mar 31) 2026 · Kansas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View →
Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q1
AARP for AARP
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Transportation
View →
Q1
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q1
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark
View →
Q1
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View →
Q1
RADIUS ADVOCACY, LLC for COUNCIL FOR INNOVATION PROMOTION (C4IP)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Copyright/Patent/Trademark
View →
Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q1
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View →
Q1
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark
View →
Q1
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for PFIZER, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark
View →
Q1
MARSHALL & POPP, LLC for GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for AMGEN USA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
THE GIBSON GROUP, LLC for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Labor Issues/Antitrust/Workplace, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · House · Senate · $25,000.00 income
Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
View →
Q4
TODD STRATEGY GROUP for PFIZER INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
3A
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
2A
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
4A
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Pharmacy, Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
Previous Page 2 of 8 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem